Here are the S-3 shelf registrations from Silence Therapeutics Plc (SLN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow SLN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SLN filings page.
Silence Therapeutics plc filed a shelf registration to offer up to $300,000,000 of ordinary shares, which may be represented by American Depositary Shares (ADSs). The prospectus states that up to $100,000,000 of ADSs are included within the $300,000,000 shelf. Each ADS represents three ordinary shares. The registration is a base shelf prospectus; specific offering amounts, prices and distribution methods will be set forth in future prospectus supplements.